Skip to main content
Top

Biotherapy

Issue 4/1998

Content (8 Articles)

Foreword

S. Eridani

The making of an erythroid cell

Anna Rita Migliaccio, Giovanni Migliaccio

Mpl ligand or thrombopoietin: Biological activities

Françoise Wendling, Karine Cohen-Solal, Jean-Luc Villeval, Najet Debili, William Vainchenker

Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources

Sandro Eridani, Umberto Mazza, Paolo Massaro, Maria Luisa La Targia, Anna Teresa Maiolo, Andrea Mosca

Hematopoietic growth factors in autologous transplantation

Gian Carlo Avanzi, Margherita Gallicchio, Giuseppe Saglio

Hodgkin’s disease: A disorder of dysregulated cellular cross-talk

Antonio Pinto, Valter Gattei, Vittorina Zagonel, Donatella Aldinucci, Massimo Degan, Angela De Iuliis, Francesca Maria Rossi, Francesca Tassan Mazzocco, Cristiana Godeas, Maurizio Rupolo, Dalisa Poletto, Annunziata Gloghini, Antonino Carbone, Hans-Jürgen Gruss

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine